BioSpace News Archive

Immuneering Corporation, a biopharmaceutical company using translational bioinformatics to advance a pipeline of product candidates designed to benefit large populations of patients with cancer and other diseases, announced that management will participate in Piper Sandler’s AI/ML Investor Conference to discuss software, artificial intelligence and bioinformatics in drug development.

Cardinal Health plans to release third-quarter financial results for its fiscal year 2022 on May 5 prior to the opening of trading on the New York Stock Exchange.

Milestone Scientific Inc., a leading developer of computerized drug delivery instruments that provide painless and precise injections, provided a business update and announced financial results for the full year ending December 31, 2021.

Anebulo Pharmaceuticals, Inc. today announced the dosing of more than half of the 60 subjects planned in Part A of an ongoing Phase 2 clinical trial at the Centre for Human Drug Research (CHDR) in the Netherlands.

Petros Pharmaceuticals, Inc. today announces financial results for the fiscal year ended December 31, 2021.

Numinus Wellness Inc. will release its financial results for the quarter ended February 28, 2022, after market close on Thursday, April 14, 2022.

Biostage Reports Fourth Quarter and Fiscal Year 2021 Financial Results.

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events.

Ocugen, Inc. announced that the first patient has been dosed in the Phase 1/2 clinical trial of OCU400.

Brain Scientific reports its business highlights and financial results for the fourth quarter and full year ended Dec. 31, 2021.